医学
心力衰竭
重症监护医学
产科
心脏病学
内科学
作者
Ersilia M. DeFilippis,Catriona Bhagra,Jillian Casale,Patricia Ging,Francesca Macera,Lynn Punnoose,Kismet Rasmusson,Garima Sharma,Karen Sliwa,Sara Thorne,Mary Norine Walsh,M. Kittleson
标识
DOI:10.1016/j.jchf.2023.07.009
摘要
Heart failure and cardiomyopathy are significant contributors to pregnancy-related deaths, as maternal morbidity and mortality have been increasing over time. In this setting, the role of the multidisciplinary cardio-obstetrics team is crucial to optimizing maternal, obstetrical and fetal outcomes. Although peripartum cardiomyopathy is the most common cardiomyopathy experienced by pregnant individuals, the hemodynamic changes of pregnancy may unmask a pre-existing cardiomyopathy leading to clinical decompensation. Additionally, there are unique management considerations for women with pre-existing cardiomyopathy as well as for those women with advanced heart failure who may be on left ventricular assist device support or have undergone heart transplantation. The purpose of this review is to discuss: 1) preconception counseling; 2) risk stratification and management strategies for pregnant women extending to the postpartum "fourth trimester" with pre-existing heart failure or "pre–heart failure;" 3) the safety of heart failure medications during pregnancy and lactation; and 4) management of pregnancy for women on left ventricular assist device support or after heart transplantation.
科研通智能强力驱动
Strongly Powered by AbleSci AI